BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez-Pizarro R, Carvajal-Vidal P, Halbault Bellowa L, Calpena AC, Espina M, García ML. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions. Colloids Surf B Biointerfaces 2019;175:365-74. [PMID: 30554015 DOI: 10.1016/j.colsurfb.2018.11.065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Suhail M, Shih C, Liu J, Hsieh W, Lin Y, Lin I, Wu P. Synthesis of glutamic acid/polyvinyl alcohol based hydrogels for controlled drug release: In-vitro characterization and in-vivo evaluation. Journal of Drug Delivery Science and Technology 2022;75:103715. [DOI: 10.1016/j.jddst.2022.103715] [Reference Citation Analysis]
2 Roig-soriano X, Souto EB, Elmsmari F, Garcia ML, Espina M, Duran-sindreu F, Sánchez-lópez E, González Sánchez JA. Nanoparticles in Endodontics Disinfection: State of the Art. Pharmaceutics 2022;14:1519. [DOI: 10.3390/pharmaceutics14071519] [Reference Citation Analysis]
3 Zafar A, Alsaidan OA, Imam SS, Yasir M, Alharbi KS, Khalid M. Formulation and Evaluation of Moxifloxacin Loaded Bilosomes In-Situ Gel: Optimization to Antibacterial Evaluation. Gels 2022;8:418. [DOI: 10.3390/gels8070418] [Reference Citation Analysis]
4 Chaudhari P, Shetty D, Lewis SA. Recent progress in colloidal nanocarriers loaded in situ gel in ocular therapeutics. Journal of Drug Delivery Science and Technology 2022;71:103327. [DOI: 10.1016/j.jddst.2022.103327] [Reference Citation Analysis]
5 Wang TZ, Guan B, Liu XX, Ke LN, Wang JJ, Nan KH. A topical fluorometholone nanoformulation fabricated under aqueous condition for the treatment of dry eye. Colloids Surf B Biointerfaces 2022;212:112351. [PMID: 35091382 DOI: 10.1016/j.colsurfb.2022.112351] [Reference Citation Analysis]
6 Esteruelas G, Halbaut L, García-Torra V, Espina M, Cano A, Ettcheto M, Camins A, Souto EB, Luisa García M, Sánchez-López E. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm 2022;612:121379. [PMID: 34915146 DOI: 10.1016/j.ijpharm.2021.121379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rincón M, Silva-Abreu M, Espinoza LC, Sosa L, Calpena AC, Rodríguez-Lagunas MJ, Colom H. Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation. Pharmaceuticals (Basel) 2021;15:22. [PMID: 35056079 DOI: 10.3390/ph15010022] [Reference Citation Analysis]
8 Pérez-González N, Bozal-de Febrer N, Calpena-Campmany AC, Nardi-Ricart A, Rodríguez-Lagunas MJ, Morales-Molina JA, Soriano-Ruiz JL, Fernández-Campos F, Clares-Naveros B. New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis. Gels 2021;7:259. [PMID: 34940319 DOI: 10.3390/gels7040259] [Reference Citation Analysis]
9 López-Machado A, Díaz N, Cano A, Espina M, Badía J, Baldomà L, Calpena AC, Biancardi M, Souto EB, García ML, Sánchez-López E. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes. Int J Pharm 2021;609:121188. [PMID: 34655707 DOI: 10.1016/j.ijpharm.2021.121188] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Shen L, Fang G, Tang B, Zhu Q. Enhanced topical corticosteroids delivery to the eye: A trade-off in strategy choice. J Control Release 2021;339:91-113. [PMID: 34560157 DOI: 10.1016/j.jconrel.2021.09.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 López-Machado A, Díaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, García ML, Sánchez-López E. Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021;13:1698. [PMID: 34683990 DOI: 10.3390/pharmaceutics13101698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
12 Hsieh WC, Fang CW, Suhail M, Lam Vu Q, Chuang CH, Wu PC. Improved skin permeability and whitening effect of catechin-loaded transfersomes through topical delivery. Int J Pharm 2021;607:121030. [PMID: 34438007 DOI: 10.1016/j.ijpharm.2021.121030] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Okur NÜ, Yağcılar AP, Siafaka PI. Promising Polymeric Drug Carriers for Local Delivery: The Case of in situ Gels. Curr Drug Deliv 2020;17:675-93. [PMID: 32510291 DOI: 10.2174/1567201817666200608145748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chen YC, Gad SF, Chobisa D, Li Y, Yeo Y. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. J Control Release 2021;330:438-60. [PMID: 33352244 DOI: 10.1016/j.jconrel.2020.12.025] [Reference Citation Analysis]
15 Gebreel RM, Edris NA, Elmofty HM, Tadros MI, El-Nabarawi MA, Hassan DH. Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study. Drug Des Devel Ther 2021;15:399-418. [PMID: 33584095 DOI: 10.2147/DDDT.S293127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
16 Jiang G, Jia H, Qiu J, Mo Z, Wen Y, Zhang Y, Wen Y, Xie Q, Ban J, Lu Z, Chen Y, Wu H, Ni Q, Chen F, Lu J, Wang Z, Li H, Chen J. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers. Int J Nanomedicine 2020;15:9373-87. [PMID: 33262593 DOI: 10.2147/IJN.S272750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Baba K, Hashida N, Tujikawa M, Quantock AJ, Nishida K. The generation of fluorometholone nanocrystal eye drops, their metabolization to dihydrofluorometholone and penetration into rabbit eyes. Int J Pharm 2021;592:120067. [PMID: 33189813 DOI: 10.1016/j.ijpharm.2020.120067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes. Pharmaceutics 2020;12:E859. [PMID: 32927595 DOI: 10.3390/pharmaceutics12090859] [Cited by in Crossref: 10] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
19 Baldim I, Oliveira WP, Kadian V, Rao R, Yadav N, Mahant S, Lucarini M, Durazzo A, Da Ana R, Capasso R, Souto SB, Santini A, Souto EB. Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems. Biomolecules 2020;10:E980. [PMID: 32630018 DOI: 10.3390/biom10070980] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mazet R, Yaméogo JBG, Wouessidjewe D, Choisnard L, Gèze A. Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation. Pharmaceutics 2020;12:E570. [PMID: 32575411 DOI: 10.3390/pharmaceutics12060570] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
21 Okur NÜ, Yozgatli V, Okur ME. In vitro–in vivo evaluation of tetrahydrozoline‐loaded ocular in situ gels on rabbits for allergic conjunctivitis management. Drug Dev Res 2020;81:716-27. [DOI: 10.1002/ddr.21677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Sánchez-López E, Esteruelas G, Ortiz A, Espina M, Prat J, Muñoz M, Cano A, Calpena AC, Ettcheto M, Camins A, Alsafi Z, Souto EB, García ML, Pujol M. Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Nanomaterials (Basel) 2020;10:E720. [PMID: 32290252 DOI: 10.3390/nano10040720] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
23 Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, Singhvi G. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv 2020;10:27835-55. [DOI: 10.1039/d0ra04971a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
24 Gonzalez-pizarro R, Parrotta G, Vera R, Sánchez-lópez E, Galindo R, Kjeldsen F, Badia J, Baldoma L, Espina M, García ML. Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides. Nanomedicine 2019;14:3089-104. [DOI: 10.2217/nnm-2019-0201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]